About Claret Capital

• Founded: 2004

• Headquarters: London, United Kingdom

• Strategy: Growth debt for technology and life sciences companies, Europe

• Thesis: Provides flexible debt financing to venture-backed growth companies as a non-dilutive alternative to equity, targeting firms that have proven product-market fit but need capital for expansion without surrendering additional ownership

• Track record: Fund III closed at approximately €300m in 2020; Fund II raised €170m in 2017

• Leadership: Founding partners include Ian Klaus and Mark Hathaway

Claret Capital Partners closed Fund IV at €440m, a 47% increase from Fund III's €300m final close four years earlier. The fund targets growth-stage technology and life sciences companies across Europe, continuing the firm's two-decade focus on non-dilutive debt financing for venture-backed businesses. The raise reflects continued LP appetite for strategies that sit between traditional venture equity and senior bank lending, particularly as more mature startups seek capital without further ownership dilution.

The jump from €300m to €440m positions Claret at the upper end of the European growth debt market but stops short of the fund-size trajectory seen among larger US peers like Trinity Capital or Horizon Technology Finance, which have scaled past $1bn in recent vintages. The 47% step-up suggests Claret is balancing scale ambitions with deployment discipline — growth debt funds that scale too quickly often face pressure to move downmarket or relax credit standards to deploy capital at pace. Fund IV's size implies Claret will need to close 20–25 deals at €15m–€25m ticket sizes to deploy efficiently, assuming a three-year investment period.

The real test will be whether Claret can maintain its historical loss rates as the fund scales. Growth debt returns hinge on keeping defaults below 5–8% of deployed capital; funds that chase volume to justify larger fund sizes often see credit quality slip in years three and four. With European venture exit activity still 40% below 2021 peaks, portfolio companies may take longer to reach liquidity events, compressing the margin for error on credit selection. If Fund IV can match Fund III's reported net returns while deploying 50% more capital, it will validate the scale thesis — if not, LPs may question whether €300m was closer to the strategy's natural ceiling.

Source: AltAssets